Page 8 - Abstracts News Today

Multiple epcoritamab (DuoBody-CD3xCD20) poster presentations highlighting data in a variety of treatment settings and hematologic malignancies Oral presentation of tisotumab vedotin first-line

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical

Multiple epcoritamab (DuoBody-CD3xCD20) studies will be presented showcasing preliminary efficacy and safety findings in a variety of patient populations in need of treatment options Several

Oral presentation of pivotal Phase 2 clinical trial of Cami in relapsed or refractory Hodgkin lymphoma ZYNLONTA diffuse large B-cell lymphoma data highlighted in several abstracts ADC Therapeutics

- Final Dataset from ARTISTRY-1 Clinical Trial to be Featured in an Oral Presentation - - Trial-in-Progress Posters From ARTISTRY-3, ARTISTRY-6 and ARTISTRY-7 Clinical Trials to be Presented

School, what is the sense of where this war is up to? —— war crime. i think today, to be honest with you, we could be starting to enter what could be a deadly holding pattern, a costly static chapter of this conflict. the reason being, yes, we are seeing the most intense fighting. we always have done, really, for the past couple of weeks in the south and south—eastern part of ukraine. that is continuing this morning. there is no doubt about that. you just need to look at the assessment fro...

STOCKHOLM, SWEDEN / ACCESSWIRE / March 22, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule

The AAID is calling for abstracts to be presented during table clinics at the 2022 AAID annual meeting to be held in Dallas, TX, September 21-24.

New data on ruxolitinib cream (Opzelura) in vitiligo and atopic dermatitis will be presented, including 52-week results from the Phase 3 TRuE-V vitiligo program which will be featured as a late-breaking

The AAID is calling for abstracts to be presented during table clinics at the 2022 AAID annual meeting to be held in Dallas, TX, September 21-24.